Roche, Gilead Reach Tamiflu Agreement

Law360, New York (November 16, 2005, 12:00 AM EST) -- As public health officials nervously prepared for a possible flu pandemic after China revealed it had identified three cases of bird flu in humans, Roche and fellow drug maker Gilead reached an agreement over royalties for the bird flu treatment Tamiflu.

The two companies have agreed to amend a 1996 licensing agreement in which Gilead, the inventor of the drug, licensed the manufacturing and distribution of the drug to Roche.

In the updated agreement, Roche will pay Gilead $62.5 million to cover royalties for 2004 and...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.